Lycopene is a carotenoid abundantly found in red vegetables. This natural pigment displays an important role in human biological systems due to its excellent antioxidant and health-supporting functions, which show a protective effect against cardiovascular diseases, hypertension, cancers, and diabetes.
Technique | Solvent/Mobile Phase/Flow Rate | Device | Temperature/ Pressure/Time/ V/Hz/rpm |
Lycopene Source/ Carotenoid Extracted |
References |
---|---|---|---|---|---|
Extraction | Hexane | Soxhlet extractor | 37 °C/6 h | Tomato peel and seed/ cis and trans-lycopene |
[19] |
* SC-CO2/1 mL·min−1 | SFT 110 extractor | 40 and 80 °C/30 and 50 MPa/30, 45, 60, 90, 120, 180, 240 min | |||
Hexane/Acetone/Ethanol (2:1:1) | Vortex | 2 h | |||
Washed in 0.1 M NaCl | Tomato peel and seed/ Lycopene and β-carotene |
[22] | |||
OH pre-treatment | 55 °C/1 min | ||||
Water/Ethanol (70%) (1:6 w/v) & |
Thermal extraction | 55 °C/15 min | |||
Water/Ethanol (1:6 w/v) & + OH solution | |||||
OH application | Ohmic heating (OH) technology (6–11 V·cm−1) pre-treatment |
0–100 °C/30 min/ 60–280 V/ 25 kHz |
|||
* SC-CO2 | |||||
Bioreactor | |||||
(37 °C, pH = 7.2, 48 h) | |||||
Escherichia coli | |||||
FA03-PM | |||||
Glucose | |||||
Glucose + oleic acid + yeast extract | |||||
Glucose + waste cooking oil + yeast extract | |||||
Lactic acid | |||||
Flask fermentation | |||||
(120 h) | |||||
B. trispora | NRRL 2895 (+) and N6 (−) | Lycopene and β-carotene |
[8] |
Delivery System | Encapsulation Method | Results | References | |||||
---|---|---|---|---|---|---|---|---|
β-cyclodextrins | A mixture of methylene chloride solution of lycopene with ethanol at 37 °C. | Higher stability against oxidizing agents (AAPH and H2O2). | [31] | |||||
β-cyclodextrins | Lycopene inclusion complexes with β-cyclodextrin were prepared by the precipitation method. |
Increased thermal stability, photostability, and antioxidant activity. | [32] | |||||
Nanoliposomes | Sonication of lycopene, soybean phosphatidylcholine, cholesterol, and aqueous solution. |
Neuronal protection against cerebral ischemia/reperfusion. Improved therapeutic efficacy and attenuated the cardiotoxicity of the chemotherapy drug doxorubicin. |
[33] | |||||
Phospholipid nanoliposomes | Nanospheres of phospholipids with lycopene produced by evaporation and nanoliposomes produced by sonication with the presence of buffer and recovered by centrifugation. |
Enhanced antioxidant activity. Prevented reactive oxygen species-induced kidney tissue damage. |
[34] | |||||
Double-loaded liposomes |
Lycopene, β-cyclodextrins encapsulated with soy lecithin and cholesterol. | Prolonged-release. Improvement of lycopene solubility. Cardioprotective activity tested in vivo. |
[35] | |||||
Oil-in-water nano-emulsions |
Octenyl succinate anhydride-modified starch mixed with lycopene using high-pressure homogenization and medium-chain triglycerides as carrier oils. | Stable nano-emulsions system with potential application for functional foods. |
[2] | |||||
Oil-in-water emulsions |
Emulsion of water, pure whey isolate, citric acid, triglycerides, and lycopene created with pressure homogenizer. | Increased lycopene bio-accessibility. System critical for the delivery of lipophilic bioactive compounds in functional drinks. |
[36] | |||||
Nanodispersions | Homogenization of lycopene dissolved in dichloromethane, aqueous phase, and Tween 20. |
Small-size lycopene nanodispersions. Good stability for application in beverage products. |
[37] | |||||
/1 L·min−1 | SFT 110 extractor | |||||||
Feed emulsions | Homogenization of tomato powders, maltodextrin, and gum Arabic in aqueous solution and encapsulation made by spray-drying. | 60 °C and 40 MPa/ 30, 45, 60, 90, 120, 180, 240 min |
Increased lycopene stability.Tomato peel and seed/ Highest |
[cis-lycopene content | 38][23] | |||
Hexane | Soxhlet extractor/0.22 µm hydrophobic PTFE | 12 h | Tomato peel and seed/ Lycopene |
[24] | ||||
Solid lipid nanoparticles (SLN) |
Lycopene-loaded solid lipid nanoparticles using Precirol® ATO 5, Compritol® 888 ATO, and myristic acid by hot homogenization. |
Stable after 2 months in an aqueous medium (4 °C). |
Olive oil | Maceration (15 to 150 min)/Magnetic stirrer/Box–Behnken | 40–80 °C/ 200–400 rpm |
|||
[ | 39 | ] | ||||||
Solid lipid nanoparticles (SLN) |
Cold homogenization technique with glyceryl monostearate and lycopene. | Gel with a promising antioxidant therapy in periodontal defects. | [40] | Methanol/Ethyl acetate/ Petroleum ether (1:1:1, v/v/v) |
Tomato peel and seed from 10 varieties/ | |||
Solid lipid nanoparticles (SLN) |
Homogenization-evaporation technique of lycopene-loaded SLN with different ratios of biocompatible Compritol® 888 ATO and gelucire. |
Particles showed in vitro anticancer activity. | Lycopene, β-carotene, and lutein | [25] | ||||
[ | 41 | ] | 30% Methanolic potassium hydroxide | Room temperature | ||||
Nanostructure lipid carriers (NLCs) | /6 h | |||||||
Ultrasonication of lycopene with | Tween 80 and Poloxamer 188. |
Enhanced oral bio-availability. Increased cytotoxicity against human breast tumor cells. |
[42] | Saturated saline solution/ Diethyl ether/ Distilled water |
Washed | |||
Nanostructure lipid carriers (NLCs) | Homogenization and ultrasonication method (aqueous phase with Tween 80, lecithin, and lycopene). | Increased lycopene aqueous solubility. Improved solubility masking tomato aftertaste. Increased homogeneity of fortified orange drink. |
[43] | Dry over anhydrous sodium sulfate |
Rotary evaporator | |||
Nanostructure lipid carriers (NLCs) | R-124 |
Emulsion created with lycopene, a lipid mixture, Tween 80 followed by pressure homogenization.35 °C | ||||||
Biphasic release pattern with fast release initially and a slower afterward. | [ | 6 | ] | PEF (pre-treatment)1,3; 5 kV·cm−1/0.012 kJ·kg−1, 0.160 kJ·kg−1, 0.475 kJ·kg−1/10 Hz/20 μs | 20 ± 2 °C | Tomato peels/ | ||
Whey protein isolate nanoparticles | Lycopene loaded whey protein isolate nanoparticles. | cis | Enhance the oral bio-availability of lycopene. Controlled release. | and all trans-lycopene | [26] | |||
Facilitated absorption through the lymphatic pathway. | [ | 17] | Acetone (1:40 w/v) & | Extraction flask | 25 °C/0–24 h /160 rpm |
|||
Gelatin nanofibers | A mixture of gelatin from bovine skin and tomato extract is used in electrospinning. | Better retention of lycopene. Better antioxidant activity during 14-days storage. |
[44] | Ethyl lactate (1:40 w/v) & | ||||
Ionic gelation | Lycopene watermelon concentrate mixed with sodium alginate or pectin. Encapsulation by dipping in CaCl2 and drying under vacuum. |
More stable lycopene-rich beads. Good application as natural colorants/antioxidants in different types of food products. |
[45] | Ethyl acetate | Thermal extraction | 75 °C/1 or 2 h | Plum tomato peels/ cis | |
Nano-encapsulation | CPCs (Chlorella pyrenoidosa cells) loaded with lycopene into a complex nutraceutical and exogenous. | and | Feasibility of lycopene encapsulation in the CPCs. Combined the activities of both materials. Novel nutraceuticals to reduce cellular oxidative stress. | all trans-lycopene | [27] | |||
[ | 10 | ] | Ultrasounds | Approximately 0 °C/30 min | ||||
Nano-emulsion | Lycopene from guava on nanoemulsifying system of natural oils. | Lycopene nano-emulsion with high stability. Significant inhibition of edema formation, suggesting a potential candidate for anti-inflammatory therapy. |
[16] | Magnesium carbonate (20%) (sample/solution 1:1) | Orbital shaker | 25 °C/2 h | Tomato peels/ Lycopene |
[3] |
Lipid-core Nanocapsules | Nano-encapsulation process mixed lycopene extract from guava with polycaprolactone polymer in acetone sorbitan monostearate. | The nanostructure was cytotoxic against cancer cells (human breast adenocarcinoma line MCF-7). | [12] | n-hexane/Acetone (3:1) | ||||
Nanoparticle | Ultrasonic | 50 °C/30 min (10 times) | ||||||
Polymer nanoparticle fucan-coated based on acetylated cashew gum and lycopene extract from guava. | Promising results for applicability in hydrophobic compounds carrying systems as lycopene with cytotoxic effect on the breast cancer cell. | [ | 11] | Centrifuge | 10 °C/10 min | |||
Microencapsulation | Microencapsulation of lycopene from tomato peels by complex coacervation and freeze-drying. |
The fine orange-yellow powder could be micro-encapsulated as stable lycopene applied to the food industry with properties against metabolic syndrome. |
[3] | Reduced volume | 40 °C/Low pressure | |||
Technique | Substrate | Device | Biological Strain | Carotenoid Produced | References | |||
Biosynthesis | Isopropyl-β-d-thiogalactoside (IPTG) as inducer |
Shaking flask (37 °C and 200 rpm) |
E. coli | Lycopene | [20] | |||
Glucose | Shake flask (30 °C, 300–600 rpm) |
S. cerevisiae | Lycopene | [21] | ||||
Glucose + Glycerol | Shake flask (37 °C, pH = 7.2, 48 h) |
Escherichia coli R122 |
Lycopene | [1] | ||||
Glucose | ||||||||
Oleic acid |